Hosted on MSN1y
Lonza to buy U.S. biologics site from Roche for $1.2B
Swiss contract drug manufacturer Lonza (OTCPK:LZAGF) (OTCPK:LZAGY) has agreed to acquire a large-scale biologics manufacturing site in California from Roche (OTCQX:RHHBY) (OTCQX:RHHBF) for $1.2B ...
Lonza Implements its Simplified and Streamlined Operating Model
Lonza Group AG / Key word (s): Miscellaneous Lonza Implements its Simplified and Streamlined Operating Model 01.04.2025 / 14:00 CET/CEST ...
The Vacaville Reporter3d
Lonza announces annual meeting
Lonza, the Swiss Biotech firm that purchased Vacaville’s Genentech plant from Roche in 2024, released a streamlined operating model and invitations to its Annual General Meeting in Basel, ...
pharmaphorum1y
Lonza adds biologics capacity with $1.2bn Roche deal
Roche is set to raise $1.2 billion from the sale of a US biologics manufacturing facility to Swiss contract development and manufacturing organisation (CDMO) Lonza, part of a drive to match ...
Contract Pharma6d
Lonza Implements Streamlined Operating Model
Lonza has announced its new streamlined operating model, effective today. Lonza’s new One Lonza vision and strategy, centered ...